Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

NCT00149214 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pemetrexed
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: docetaxel

Sponsor

Eli Lilly and Company